Sepiapterin reductase regulation of endothelial tetrahydrobiopterin and nitric oxide bioavailability

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 1, 2009, Pages

  Gao, Ling ^a   Pung, Yuh Fen ^a   Zhang, Jun ^a   Chen, Peng ^a   Wang, Ting ^a   Li, Min ^a   Meza, Miguel ^a   Toro, Ligia ^a   Cai, Hua ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aortic endothelial cells; Dihydrofolate reductase; Endothelial nitric oxide synthase; Guanosine 5 triphosphate cyclohydrolase 1

Indexed keywords

DIHYDROFOLATE REDUCTASE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; NITRIC OXIDE; SEPIAPTERIN; SEPIAPTERIN REDUCTASE; TETRAHYDROBIOPTERIN;

AMINO ACID SEQUENCE; ANIMAL CELL; AORTA; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME REGULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEQUENCE ALIGNMENT;

ALCOHOL OXIDOREDUCTASES; AMINO ACID SEQUENCE; ANIMALS; BIOPTERIN; CATTLE; CELLS, CULTURED; CLONING, MOLECULAR; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NITRIC OXIDE; PTERINS; RNA INTERFERENCE; TRANSFECTION; VASODILATION;

EID: 67650088296     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00007.2009     Document Type: Article

References (44)

1. Alp NJ, McAteer MA, Khoo J, Choudhury RP, Channon KM. Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice. Arterioscler Thromb Vasc Biol 24: 445-450, 2004.
2. Blau N, Bonafe L, Thony B. Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. Mol Genet Metab 74: 172-185, 2001.
3. Cai S, Khoo J, Channon KM. Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells. Cardiovasc Res 65: 823-831, 2005.
4. Chalupsky K, Cai H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 102: 9056-9061, 2005.
5. Citron BA, Milstien S, Gutierrez JC, Levine RA, Yanak BL, Kaufman S. Isolation and expression of rat liver sepiapterin reductase cDNA. Proc Natl Acad Sci USA 87: 6436-6440, 1990.
6. Crabtree MJ, Tatham AL, Al-Wakeel Y, Warrick N, Hale AB, Cai S, Channon KM, Alp NJ. Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterineNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression. J Biol Chem 284: 1136-1144, 2009.
7. Du YH, Guan YY, Alp NJ, Channon KM, Chen AF. Endothelium-specific GTP cyclohydrolase I overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension. Circulation 117: 1045-1054, 2008.
8. Ferre J, Naylor EW. Sepiapterin reductase in human amniotic and skin fibroblasts, chorionic villi, and various blood fractions. Clin Chim Acta 174: 271-282, 1988.
9. Fiege B, Ballhausen D, Kierat L, Leimbacher W, Goriounov D, Schircks B, Thony B, Blau N. Plasma tetrahydrobiopterin and its pharmacokinetic following oral administration. Mol Genet Metab 81: 45-51, 2004.
10. Heitzer T, Brockhoff C, Mayer B, Warnholtz A, Mollnau H, Henne S, Meinertz T, Munzel T. Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase. Circ Res 86: E36-E41, 2000.
11. Ichinose H, Katoh S, Sueoka T, Titani K, Fujita K, Nagatsu T. Cloning and sequencing of cDNA encoding human sepiapterin reductase-an enzyme involved in tetrahydrobiopterin biosynthesis. Biochem Biophys Res Commun 179: 183-189, 1991.
12. Ishii M, Shimizu S, Momose K, Yamamoto T. SIN-1-induced cytotoxicity in cultured endothelial cells involves reactive oxygen species and nitric oxide: protective effect of sepiapterin. J Cardiovasc Pharmacol 33: 295-300, 1999.
13. Kerler F, Hultner L, Ziegler I, Katzenmaier G, Bacher A. Analysis of the tetrahydrobiopterin synthesizing system during maturation of murine reticulocytes. J Cell Physiol 142: 268-271, 1990.
14. Kinoshita H, Milstien S, Wambi C, Katusic ZS. Inhibition of tetrahydrobiopterin biosynthesis impairs endothelium-dependent relaxations in canine basilar artery. Am J Physiol Heart Circ Physiol 273: H718-H724, 1997.
15. Korda M, Kubant R, Patton S, Malinski T. Leptin-induced endothelial dysfunction in obesity. Am J Physiol Heart Circ Physiol 295: H1514-H1521, 2008.
16. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111: 1201-1209, 2003.
17. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948, 2007.
18. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, Harrison DG. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103: 1282-1288, 2001.
19. Lee J, Hargest R, Wasan H, Phillips RK. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model. Dis Colon Rectum 47: 2105-2113, 2004.
20. Lee SW, Park IY, Hahn Y, Lee JE, Seong CS, Chung JH, Park YS. Cloning of mouse sepiapterin reductase gene and characterization of its promoter region. Biochim Biophys Acta 1445: 165-171, 1999.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-delta delta C(T)] method. Methods 25: 402-408, 2001.
22. Matsubara M, Akino M. On the presence of sepiapterin reductase different from folate and dihydrofolate reductase in chicken liver. Experientia 20: 574-575, 1964.
23. Matsubara M, Katoh S, Akino M, Kaufman S. Sepiapterin reductase. Biochim Biophys Acta 122: 202-212, 1966.
24. Matsuda N, Takano Y, Kageyama S, Hatakeyama N, Shakunaga K, Kitajima I, Yamazaki M, Hattori Y. Silencing of caspase-8 and caspase-3 by RNA interference prevents vascular endothelial cell injury in mice with endotoxic shock. Cardiovasc Res 76: 132-140, 2007.
25. Milstien S, Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun 263: 681-684, 1999.
26. Mitchell BM, Dorrance AM, Ergul A, Webb RC. Sepiapterin decreases vasorelaxation in nitric oxide synthase inhibition-induced hypertension. J Cardiovasc Pharmacol 43: 93-98, 2004.
27. Moat SJ, Ashfield-Watt PA, Powers HJ, Newcombe RG, McDowell IF. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype. Clin Chem 49: 295-302, 2003.
28. Moens AL, Kass DA. Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease. J Cardiovasc Pharmacol 50: 238-246, 2007.
29. Munzel T, Sinning C, Post F, Warnholtz A, Schulz E. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med 40: 180-196, 2008.
30. Oak JH, Cai H. Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice. Diabetes 56: 118-126, 2007.
31. Oyama R, Katoh S, Sueoka T, Suzuki M, Ichinose H, Nagatsu T, Titani K. The complete amino acid sequence of the mature form of rat sepiapterin reductase. Biochem Biophys Res Commun 173: 627-631, 1990.
32. Ozkor MA, Quyyumi AA. Tetrahydrobiopterin. Curr Hypertens Rep 10: 58-64, 2008.
33. Pou S, Pou WS, Bredt DS, Snyder SH, Rosen GM. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem 267: 24173-24176, 1992.
34. Schmidt TS, Alp NJ. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clin Sci (Lond) 113: 47-63, 2007.
35. Schulz E, Jansen T, Wenzel P, Daiber A, Munzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 10: 1115-1126, 2008.
36. Seong C, Kim YA, Chung HJ, Park D, Yim J, Baek K, Park YS, Han K, Yoon J. Isolation and characterization of the Drosophila melanogaster cDNA encoding the sepiapterin reductase. Biochim Biophys Acta 1443: 239-244, 1998.
37. Sueoka T, Katoh S. Purification and characterization of sepiapterin reductase from rat erythrocytes. Biochim Biophys Acta 717: 265-271, 1982.
38. Tarpey MM. Sepiapterin treatment in atherosclerosis. Arterioscler Thromb Vasc Biol 22: 1519-1521, 2002.
39. Thony B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 347: 1-16, 2000.
40. Vasquez-Vivar J, Hogg N, Martasek P, Karoui H, Pritchard KA Jr, Kalyanaraman B. Tetrahydrobiopterin-dependent inhibition of superoxide generation from neuronal nitric oxide synthase. J Biol Chem 274: 26736-26742, 1999.
41. Werner-Felmayer G, Golderer G, Werner ER. Tetrahydrobiopterin biosynthesis, utilization and pharmacological effects. Curr Drug Metab 3: 159-173, 2002.
42. Wever RM, van Dam T, van Rijn HJ, de Groot F, Rabelink TJ. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun 237: 340-344, 1997.
43. Zerr-Fouineau M, Jourdain M, Boesch C, Hecker M, Bronner C, Schini-Kerth VB. Certain progestins prevent the enhancing effect of 17beta-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells. Arterioscler Thromb Vasc Biol 29: 586-593, 2009.
44. Zheng JS, Yang XQ, Lookingland KJ, Fink GD, Hesslinger C, Kapatos G, Kovesdi I, Chen AF. Gene transfer of human guanosine 5′-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Circulation 108: 1238-1245, 2003.